Info

Generation ETFs

Generation ETFs, a podcast series dedicated to the next generation of investing. Generation ETFs will aim to educate and inspire investors to understand and be active in their portfolios by discussing market trends and investment strategies with the leading experts in the industry.
RSS Feed
Generation ETFs
2021
September
July
June
May
April
February


2020
December
October
August
June
April
March
February


2019
October
September
August
May
April


2016
May
March
February


2015
October
July
June


All Episodes
Archives
Now displaying: February, 2021
Feb 8, 2021

After years of restrictions, Psychedelic compounds like psilocybin, ketamine and MDMA have been permitted to once again be studied and adapted into potential therapies for a variety of mental illnesses and could spark a revolution in the pharmaceutical industry. Join Mark Noble, Executive Vice President, ETF Strategy at Horizons ETFs as he speaks to psychedelics analyst Tania Gonsalves, Vice President, Equity Research at Canaccord Genuity about the emerging psychedelics industry and which companies are leading the way to unlocking potent new ways of treating mental illnesses.

1